Form 4 Tracker
INCYTE CORP
INCY

22 insider filings · Latest: May 8, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Apr 17, 2026Apr 21 8:09 PMPablo J CagnoniPresident, Global Head of R&D
Sale
18,667$96.50$1.8M262,692(D)

View →

Apr 17, 2026Apr 17 8:07 PMPABLO CAGNONI
Proposed Sale
18,667$96.50$1.8M

View →

Mar 17, 2026Mar 19 8:20 PMPablo J CagnoniPresident, R&D
Sale
18,667$94.24$1.8M234,800(D)

View →

Mar 17, 2026Mar 17 8:07 PMPABLO CAGNONI
Proposed Sale
18,667$94.24$1.8M

View →

Feb 19, 2026Feb 23 9:05 PMPablo J CagnoniPresident, R&D
Sale
18,668$100.91$1.9M234,800(D)

View →

Feb 19, 2026Feb 19 9:02 PMPABLO CAGNONI
Proposed Sale
18,668$100.91$1.9M

View →

Feb 9, 2026Feb 9 10:14 PMVIJAY IYENGAR
Proposed Sale
12,743$109.00$1.4M

View →

Jan 7, 2026Jan 7 9:01 PMMOHAMED ISSA
Proposed Sale
10,856$109.07$1.2M

View →

Jan 6, 2026Jan 6 9:05 PMVIJAY IYENGAR
Proposed Sale
95,811$104.35$10.0M

View →

Jan 5, 2026Jan 5 9:34 PMVIJAY IYENGAR
Proposed Sale
16,437$102.81$1.7M

View →

Jan 5, 2026Jan 5 9:06 PMSTEVEN STEIN
Proposed Sale
15,634$101.70$1.6M

View →

Dec 19, 2025Dec 19 9:06 PMVIJAY IYENGAR
Proposed Sale
52,941$101.73$5.4M

View →

Dec 19, 2025Dec 19 9:05 PMTHOMAS R TRAY
Proposed Sale
2,774$100.00$277.4K

View →

Dec 18, 2025Dec 18 9:12 PMTHOMAS R TRAY
Proposed Sale
600$98.25$59.0K

View →

Dec 17, 2025Dec 17 9:01 PMMICHAEL MORRISSEY
Proposed Sale
4,323$97.26$420.5K

View →

Dec 16, 2025Dec 16 9:53 PMVIJAY IYENGAR
Proposed Sale
13,388$98.39$1.3M

View →

Dec 16, 2025Dec 16 9:15 PMMICHAEL MORRISSEY
Proposed Sale
54,008$97.29$5.3M

View →

Dec 15, 2025Dec 15 10:31 PMCHRISTIANA STAMOULIS
Proposed Sale
187,690$97.00$18.2M

View →

Dec 11, 2025Dec 11 9:13 PMPATRICK A MAYES
Proposed Sale
255$94.94$24.2K

View →

Dec 10, 2025Dec 10 10:29 PMVIJAY IYENGAR
Proposed Sale
23,104$95.51$2.2M

View →

Page 1 of 4

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
May 8, 2026May 11 8:45 PMBAKER BROS. ADVISORS LPDirector, 10% Owner
Option Exercise
30,000$84.530(I)

View →

May 4, 2026May 6 8:34 PMSuketu UpadhyayEVP & Chief Financial Officer
Grant/Award
51,600$97.1426,342(D)

View →

Apr 17, 2026Apr 21 8:09 PMPablo J CagnoniPresident, Global Head of R&D
Option Exercise
18,667$71.9327,699(D)

View →

Mar 17, 2026Mar 19 8:20 PMPablo J CagnoniPresident, R&D
Option Exercise
18,667$64.2532,910(D)

View →

Feb 19, 2026Feb 23 9:05 PMPablo J CagnoniPresident, R&D
Option Exercise
18,668$61.7616,268(D)

View →

Jan 16, 2026Jan 21 9:06 PMPablo J CagnoniPresident, R&D
Grant/Award
28,475$106.2128,475(D)

View →

Jan 16, 2026Jan 21 9:06 PMSteven H SteinEVP & Chief Medical Officer
Grant/Award
19,932$106.2119,932(D)

View →

Jan 16, 2026Jan 21 9:06 PMMohamed Khairie IssaEVP, Head of US Oncology
Grant/Award
14,237$106.2114,237(D)

View →

Jan 16, 2026Jan 21 9:05 PMMatteo TrottaEVP, GM, Dermatology US
Grant/Award
8,542$106.218,542(D)

View →

Jan 16, 2026Jan 21 9:04 PMThomas TrayPrincipal Accounting Officer
Grant/Award
2,425$106.212,425(D)

View →

Jan 16, 2026Jan 21 9:04 PMPatrick A MayesEVP & Chief Scientific Officer
Grant/Award
4,218$106.214,218(D)

View →